ONCO CIK: 1782107

Onconetix, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
3.07
FY22:
26.3
FY23:
5.84
FY24:
0.95
FY25:
6.07
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.01
FY22:
0.05
FY23:
81.7
FY24:
27.2
FY25:
18.9
Total assets
Change from FY21 to FY25
millions USD
FY21:
3.08
FY22:
26.3
FY23:
87.5
FY24:
28.2
FY25:
24.9

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
1.64
FY22:
3.92
FY23:
17.2
FY24:
18.3
FY25:
9.14
(negative)
millions USD
FY21:
0
FY22:
0
FY23:
4.69
FY24:
0.28
FY25:
0.02
(positive)
Change from FY21 to FY25
millions USD
FY21:
1.45
FY22:
22.4
FY23:
−5.60
FY24:
8.54
FY25:
15.8
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
3.08
FY22:
26.3
FY23:
–
FY24:
–
FY25:
24.9

All amounts in millions USD Data source:SEC EDGAR